Status:
COMPLETED
Application of Carbon Dioxide for Identifying the Intersegmental Plane in Thoracoscopic Segmentectomy
Lead Sponsor:
Tongji Hospital
Conditions:
Lung Cancer
Pulmonary Nodule, Solitary
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
With the increasing acceptance of routine computed tomography (CT) screenings, early-stage lung cancer detection is becoming more frequent. For ground glass opacity predominant early-stage lung cancer...
Detailed Description
This study was approved by the ethics committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. This randomized parallel group trial enrolled patients schedu...
Eligibility Criteria
Inclusion
- 18-80 years of age.
- Segmentectomy is feasible according to the reconstructed 3-dimensional (3D) images.
- Pulmonary nodule 2 cm or smaller in diameter with 50% or more ground-glass opacity (GGO) on thin-slice computed tomography, indicating an underlying malignancy.
- Ability to provide written informed consent.
- Unable to tolerate lobectomy as indicated by standard clinical pre-op evaluation, including pulmonary function tests and cardiac evaluation.
- Diagnosis confirmed or suspected of lung metastatic cancer.
Exclusion
- Patients who are at risk for general anesthesia.
- Patients with serious mental illness.
- Pregnancy or lactating women.
- Active bacterial or fungal infections.
- Panties with Interstitial pneumonia, pulmonary fibrosis or severe emphysema.
- Conversion to thoracotomy in surgery.
- Preoperative assessment of patients undergoing lobectomy.
Key Trial Info
Start Date :
February 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 11 2022
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT05350137
Start Date
February 11 2022
End Date
May 11 2022
Last Update
February 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji hospital
Wuhan, Hubei, China, 430030